VEEV Stock Recent News

In the closing of the recent trading day, Veeva Systems (VEEV) stood at $239.53, denoting a +0.51% change from the preceding trading day.

PLEASANTON, Calif. , May 7, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its first quarter, which ended April 30, 2025, after market close on May 28, 2025.

AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Company, and more share strategies for more connected customer experiences across sales, marketing, and medical PLEASANTON, Calif. , May 6, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its keynote speakers for the 2025 Veeva Commercial Summit, May 13-14 in Boston.

I believe Veeva's robust product roadmap, including the introduction of Veeva AI, should deepen adoption and drive productivity across its Development and Commercial Cloud segments. Despite a projected revenue growth slowdown in FY26, Veeva's management remains confident in achieving its $6B revenue target by 2030. VEEV's strong financial discipline is evident, with non-GAAP operating margins expected to expand to 43% in FY26 despite a projected revenue slowdown.

DELRAY BEACH, Fla., May 2, 2025 /PRNewswire/ -- The global Life Science Analytics Market , valued at US$35.69 billion in 2024, is forecasted to grow at a robust CAGR of 11.4%, reaching US$40.03 billion in 2025 and an impressive US$68.81 billion by 2030. The standardization of diverse datasets from sources such as clinical trials, electronic health records (EHRs), genomics, and real-world evidence is essential for the efficient exchange of information across various platforms and geographical regions. This standardization enhances multi-site clinical trials and cross-border research collaborations. Additionally, emerging technologies like artificial intelligence (AI), quantum computing, and cognitive computing play a vital role in transforming large volumes of raw data into actionable insights. These technologies help simplify reports and create interactive dashboards. Furthermore, the increasing adoption of analytics in pre-clinical trials, drug discovery, and clinical trials, particul

Veeva Systems (VEEV) closed the most recent trading day at $232.07, moving -0.69% from the previous trading session.

Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Major new initiative will add AI to Veeva applications and the Veeva Vault Platform to help automate critical industry-specific functions and improve productivity from clinical to commercial PLEASANTON, Calif. , April 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI, a major new initiative that adds AI to the Veeva Vault Platform and Veeva applications to help life sciences companies automate tasks and improve employee productivity using AI Agents and AI Shortcuts.

Veeva Systems (VEEV) closed the most recent trading day at $227.11, moving -0.26% from the previous trading session.

VEEV's robust product portfolio and a slew of strategic deals raise optimism about the stock.